China Pioneer Pharma Holdings Ltd
HKEX:1345
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| CN |
|
China Pioneer Pharma Holdings Ltd
HKEX:1345
|
2.9B HKD |
Loading...
|
|
| US |
|
Mckesson Corp
NYSE:MCK
|
101.7B USD |
Loading...
|
|
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
70.3B USD |
Loading...
|
|
| US |
|
Cencora Inc
NYSE:COR
|
64B USD |
Loading...
|
|
| US |
|
Cardinal Health Inc
NYSE:CAH
|
49.4B USD |
Loading...
|
|
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
36.6B AUD |
Loading...
|
|
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
64B CNY |
Loading...
|
|
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
63.9B CNY |
Loading...
|
|
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.9B USD |
Loading...
|
|
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
65.4B HKD |
Loading...
|
|
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW |
Loading...
|
Market Distribution
| Min | -409 046.1% |
| 30th Percentile | -1.4% |
| Median | 4.2% |
| 70th Percentile | 10.3% |
| Max | 876.4% |
Other Profitability Ratios
China Pioneer Pharma Holdings Ltd
Glance View
China Pioneer Pharma Holdings Ltd. is an investment holding company, which engages in the manufacture, promotion, and sale of pharmaceutical products. The company is headquartered in Shanghai, Shanghai and currently employs 250 full-time employees. The company went IPO on 2013-11-05. The firm operates through two business segments. The Ophthalmic Pharmaceutical Products segment is engaged in the sales of ophthalmic pharmaceutical products by provision of channel management services and co-promotion services. The Products Sold Via the Provision of Comprehensive Marketing, Promotion and Channel Management Services segment is engaged in the sales of all pharmaceutical products and medical devices except for ophthalmic pharmaceutical products. The firm is also engaged in the manufacturing of chemical and pharmaceutical products through its subsidiaries.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for China Pioneer Pharma Holdings Ltd is 13.3%, which is below its 3-year median of 13.3%.
Over the last 3 years, China Pioneer Pharma Holdings Ltd’s Operating Margin has decreased from 14.9% to 13.3%. During this period, it reached a low of 11.6% on Dec 31, 2023 and a high of 15.8% on Dec 31, 2022.
